Purchase Biolog Odin Phenotype Microarrray Instrument

The Food and Drug Administration is forecasting the purchase of two Biolog Odin Phenotype Microarray instruments—one fully funded and one unfunded—to enhance the characterization of bacterial foodborne pathogens such as Salmonella, STEC, and Listeria monocytogenes. These advanced proteomic measuring devices will support the agency’s scientific efforts in identifying and understanding the phenotypic traits of pathogenic bacteria critical to food safety and public health. The acquisition is intended to strengthen the laboratory’s capacity for rapid, high-throughput analysis of microbial responses under varying environmental and stress conditions, improving detection and response capabilities in outbreak investigations and regulatory assessments. The solicitation is categorized under NAICS code 541990, indicating it falls within other scientific and technical services, and is posted with no set-aside designation, suggesting it is open to all eligible vendors. The point of contact for program inquiries is the Hfp Acquisition Liaison at hfpacquisitions@fda.hhs.gov, while the contracting officer position is currently vacant and will be filled prior to formal solicitation. The contract does not specify a physical place of performance, indicating that delivery and installation may occur at FDA laboratories nationwide, and no city, state, or zip information has been provided. The forecast was made public on May 25, 2026, and further details will be released through the OSDBU portal prior to any formal procurement action.